RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $178
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Johnson & Johnson and raises the price target from $175 to $178.
October 08, 2024 | 6:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its Outperform rating on Johnson & Johnson and increased the price target from $175 to $178, indicating a positive outlook.
The increase in price target from $175 to $178 by RBC Capital suggests a positive outlook for Johnson & Johnson, likely boosting investor confidence and potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100